It was approved by the FDA in 2021 for chronic weight management in adults with obesity or overweight with at least one weight-related condition
The development of brain white matter microstructure
When your infusion is complete, we'll remove the IV line, apply a small bandage, and give you post-treatment recommendations
Some common side effects of Semaglutide include nausea, vomiting, diarrhea, and constipation, all of which involve the gastrointestinal (GI) system
Physical indicators during use Pay attention to how the medication feels and behaves during and after injection
However, the largest Phase IIb trial involving 536 subjects failed to demonstrate statistically significant weight loss compared to placebo at the primary 12-week endpoint, leading Metabolic Pharmaceuticals to terminate development in 2007